Sheppard Riva - 21 May 2025 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role: Co-Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Riva Sheppard
Issuer symbol: INBP
Transactions as of: 21 May 2025
Net transactions value: +$13,000
Form type: 4
Filing time: 22 May 2025, 17:57:37 UTC
Previous filing: 05 Dec 2024
Next filing: 10 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
RIVA SHEPPARD	Co-Chief Executive Officer, Director, 10%+ Owner	C/O 225 LONG AVENUE, HILLSIDE	/s/ Riva Sheppard	22 May 2025	0001064900

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INBP	Common Stock	Award	$13,000	+144,445	+11%	$0.0900	1,473,467	21 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INBP	Stock Option (Right to Buy)	Disposed to Issuer	$0	-144,445	-100%	$0.000000	0	21 May 2025	Common Stock	144,445	$0.0900	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	144,445 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
F2	81,945 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.